Rollout Map
Sign Up
S. 331 Senate Crime and Law Enforcement

HALT Fentanyl Act

Introduced
Jan 30, 2025
Sponsor
Sen. Cassidy, Bill (R-LA)
View on Congress.gov

BECAME LAW JUL 16, 2025

Became Law on Jul 16, 2025.

  1. Senate Introduced in Senate Jan 30, 2025
  2. Senate Read twice and referred to the Committee on the Judiciary. Jan 30, 2025
  3. Senate Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. Feb 27, 2025
  4. Senate Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report. Mar 3, 2025
  5. Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 18. Mar 3, 2025
  6. Senate Motion to proceed to consideration of measure made in Senate. (CR S1488) Mar 4, 2025
  7. Senate Cloture motion on the motion to proceed to the measure presented in Senate. (CR S1488) Mar 4, 2025
  8. Senate Motion to proceed to measure considered in Senate. (CR S1521) Mar 5, 2025
  9. Senate Motion to proceed to measure considered in Senate. (CR S1596) Mar 6, 2025
  10. Senate Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 82 - 12. Record Vote Number: 110. (CR S1596) Mar 6, 2025
  11. Senate
    On Cloture on the Motion to Proceed S. 331 Mar 6, 2025
    Agreed Yea 82 Nay 12 Roll Call
  12. Senate Motion to proceed to measure considered in Senate. (CR S1623) Mar 10, 2025
  13. Senate Motion to proceed to consideration of measure agreed to in Senate by Voice Vote. (consideration: CR S1623) Mar 10, 2025
  14. Senate Measure laid before Senate by motion. Mar 10, 2025
  15. Senate Considered by Senate. (consideration: CR S1659) Mar 11, 2025
  16. Senate Cloture motion on the measure presented in Senate. (CR S1659) Mar 11, 2025
  17. Senate Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124. (CR S1735) Mar 13, 2025
  18. Senate Considered by Senate. (consideration: CR S1735) Mar 13, 2025
  19. Senate
    On the Cloture Motion S. 331 Mar 13, 2025
    Agreed Yea 84 Nay 15 Roll Call
  20. Senate Considered by Senate. (consideration: CR S1762-1765) Mar 14, 2025
  21. Senate The committee substitute agreed to by Unanimous Consent. Mar 14, 2025
  22. Senate Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127. Mar 14, 2025
  23. Senate Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127. Mar 14, 2025
  24. Senate Message on Senate action sent to the House. Mar 14, 2025
  25. Senate
    On Passage of the Bill S. 331 Mar 14, 2025
    Agreed Yea 84 Nay 16 Roll Call
  26. House Received in the House. Mar 18, 2025
  27. House Held at the desk. Mar 18, 2025
  28. House Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331. Jun 9, 2025
  29. House Rule H. Res. 489 passed House. Jun 10, 2025
  30. House Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633) Jun 11, 2025
  31. House Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331. Jun 11, 2025
  32. House DEBATE - The House proceeded with one hour of debate on S. 331. Jun 11, 2025
  33. House The previous question was ordered pursuant to the rule. Jun 11, 2025
  34. House POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced. Jun 11, 2025
  35. House Considered as unfinished business. (consideration: CR H2806) Jun 12, 2025
  36. Senate Passed/agreed to in House: On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627) Jun 12, 2025
  37. House On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627) Jun 12, 2025
  38. House Motion to reconsider laid on the table Agreed to without objection. Jun 12, 2025
  39. House
    On Passage Jun 12, 2025
    Agreed Yea 321 Nay 104 Roll Call
  40. Senate
    Presented to President. Jul 8, 2025
  41. Senate
    Signed by President. Jul 16, 2025
  42. Senate Latest action
    Became Public Law No: 119-26. Jul 16, 2025

Cosponsors

31

Subjects

Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrationsResearch administration and funding

Committees

  • Judiciary Committee
    • Reported By , Mar 3, 2025
    • Markup By , Feb 27, 2025
    • Referred To , Jan 30, 2025

Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the act establishes a new, alternative registration process for certain schedule I research.

The act also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Summary as of: Public Law

Bill Text

Formatted Text PDF Formatted XML

Related Bills

Comments · 0

Loading comments...